Основная статистика
| CIK | 907562 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Dyax Corp.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| February 12, 2016 |
DYAX / Dyax Corp. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D. |
|
| February 9, 2016 |
DYAX / Dyax Corp. / FEDERATED INVESTORS INC /PA/ Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 17)* DYAX CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 26746E103 (CUSIP Number) January 31, 2016 (Date of Event Which Requires Filing of this Stat |
|
| February 8, 2016 |
DYAX / Dyax Corp. / FEDERATED INVESTORS INC /PA/ Passive Investment OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 16)* DYAX CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Sta |
|
| February 1, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-24537 DYAX CORP. (Exact name of registrant as specified in its charter) |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
S-8 POS 1 a16-27054s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. 333-49852 Registration No. 333-49856 Registration No. 333-97523 Registration No. 333-97527 Registration No. 333-105842 Registration No. 333-119607 Registration No. 333-131416 Registration No. 333-146154 Registration No. 333-146155 Registration No. 333-168566 Registration N |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
STATE of DELAWARE AMENDED AND RESTATED BYLAWS CORP. * * * * * ARTICLE 1 EX-3.2 3 a16-270516ex3d2.htm EX-3.2 Exhibit 3.2 STATE of DELAWARE AMENDED AND RESTATED BYLAWS OF BYLAWS CORP. * * * * * ARTICLE 1 OFFICES Section 1.01. Registered Office. The registered office of the Corporation shall be in the City of Wilmington, County of New Castle, State of Delaware. Section 1.02. Other Offices. In addition to its registered office in the State of Delaware, the Corporation may |
|
| January 22, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 21, 2016 DYAX CORP. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
Exhibit 99.1 Press Release www.shire.com Shire Completes Acquisition of Dyax Lexington, Mass. ? January 22, 2016 ? Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it has completed its acquisition of Dyax Corp. (NASDAQ: DYAX) in an all-cash transaction valued at approximately $5.9 billion, comprised of $37.30 in cash per Dyax share. Dyax shareholders may receive additional value through a n |
|
| January 22, 2016 |
STATE of DELAWARE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION DYAX CORP. * * * * * EX-3.1 2 a16-270516ex3d1.htm EX-3.1 Exhibit 3.1 STATE of DELAWARE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DYAX CORP. * * * * * FIRST: The name of the corporation is Dyax Corp. (the “Corporation”). SECOND: The address of its registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801. The name of i |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 22, 2016 |
As filed with the Securities and Exchange Commission on January 22, 2016 Registration No. |
|
| January 14, 2016 |
EX-10.5 3 dyaxamendedxexhibit105.htm EXHIBIT 10.5 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10 |
|
| January 14, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 ý Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-24537 |
|
| January 14, 2016 |
EX-10.4 2 dyaxamendedxexhibit104.htm EXHIBIT 10.4 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10 |
|
| December 14, 2015 |
Proxy Statement Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 11, 2015 |
EX-99.1 Exhibit 99.1 Contact: Jennifer Robinson Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire plc BURLINGTON, MA, December 11, 2015 ? Dyax Corp. (NASDAQ: DYAX) (?Dyax?) today announced it has set a date for a special meeting of its stock |
|
| December 11, 2015 |
Financial Statements and Exhibits, Other Events Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2015 Dyax Corp. |
|
| December 11, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 11, 2015 Dyax Corp. |
|
| December 11, 2015 |
EX-99.1 Exhibit 99.1 Contact: Jennifer Robinson Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Corp. Sets January 21, 2016 As Date of Special Stockholder Meeting To Vote On Its Proposed Acquisition By Shire plc BURLINGTON, MA, December 11, 2015 ? Dyax Corp. (NASDAQ: DYAX) (?Dyax?) today announced it has set a date for a special meeting of its stock |
|
| December 10, 2015 |
Correspondence Via EDGAR Mr. John Reynolds Assistant Director Office of Beverages, Apparel, and Mining Division of Corporation Finance United States Securities and Exchange Commission Washington, D.C. 20549 December 10, 2015 Re: Dyax Corp. Preliminary Proxy Statement on Schedule 14A Filed November 23, 2015 File No. 000-24537 Dear Mr. Reynolds: On behalf of Dyax Corp., a Delaware corporation (the ? |
|
| December 2, 2015 |
Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period EX-99.1 2 d58694dex991.htm EX-99.1 Exhibit 99.1 Contact: Jennifer Robinson Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period BURLINGTON, MA, December 2, 2015 – Dyax Corp. (NASDAQ: DYAX) (“Dyax”) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvemen |
|
| December 2, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2015 Dyax Corp. |
|
| December 2, 2015 |
Financial Statements and Exhibits, Other Events 8-K 1 d58694d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 2, 2015 Dyax Corp. (Exact name of Registrant as specified in its charter) Delaware 000-24537 04-3053198 (State or other jurisdiction of incorporati |
|
| December 2, 2015 |
Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period EX-99.1 Exhibit 99.1 Contact: Jennifer Robinson Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Corp. Announces Early Termination of Hart-Scott-Rodino Waiting Period BURLINGTON, MA, December 2, 2015 ? Dyax Corp. (NASDAQ: DYAX) (?Dyax?) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended |
|
| November 23, 2015 |
Dyax PRELIMINARY PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Rule 14a-101) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| November 6, 2015 |
EX-10.1 2 a93015exhibit101.htm EXHIBIT 10.1 Exhibit 10.1 Notice of Grant of Stock Options DYAX CORP. and Option Agreement ID: 04-3053198 55 Network Drive Burlington, MA 01803 Option Number: Plan: 1995 ID: Effective (the “Date of Grant”), you have been granted an Incentive Stock Option (the “Option”) to buy shares of DYAX CORP. (the “Company”) stock at $ per share, which is the closing price of the |
|
| November 6, 2015 |
EX-10.5 6 a93015exhibit105.htm EXHIBIT 10.5 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.5 Man |
|
| November 6, 2015 |
EX-10.2 3 a93015exhibit102.htm EXHIBIT 10.2 Exhibit 10.2 Notice of Grant of Stock Options DYAX CORP. and Option Agreement ID: 04-3053198 55 Network Drive Burlington, MA 01803 Option Number: Plan: 1995 ID: Effective (the “Date of Grant”), you have been granted a Non-Qualified Stock Option (the “Option”) to buy shares of DYAX CORP. (the “Company”) stock at $ per share, which is the closing price of |
|
| November 6, 2015 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.4 Master Development & Manufacturing Services Agr |
|
| November 6, 2015 |
DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT CERTIFICATE EX-10.3 4 a93015exhibit103.htm EXHIBIT 10.3 Exhibit 10.3 DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT CERTIFICATE (Employees) Certificate Number: RSU- Units This Restricted Stock Unit Certificate (this “Certificate”) confirms that Dyax Corp. (“Dyax” or the “Company”), a Delaware corporation, has on the date set forth below (the “Award Date”) granted to the perso |
|
| November 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2015 Or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-24537 DYAX CORP. (Exact |
|
| November 2, 2015 |
Dyax FORM 8-K (Current Report/Significant Event) Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2015 Dyax Corp. |
|
| November 2, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State |
|
| November 2, 2015 |
Exhibit 10.1 Exhibit 10.1 CONTINGENT VALUE RIGHTS AGREEMENT By and between SHIRE PLC and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC as Rights Agent Dated as of [?], 2015 TABLE OF CONTENTS Page Article I Definitions 1.1 Definitions 1 1.2 Additional Definitions 4 1.3 Other Definitional Provisions 5 Article II Contingent Value Rights 2.1 CVRs 5 2.2 Nontransferable 5 2.3 No Certificate; Registration |
|
| November 2, 2015 |
Exhibit 10.1 Exhibit 10.1 CONTINGENT VALUE RIGHTS AGREEMENT By and between SHIRE PLC and AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC as Rights Agent Dated as of [?], 2015 TABLE OF CONTENTS Page Article I Definitions 1.1 Definitions 1 1.2 Additional Definitions 4 1.3 Other Definitional Provisions 5 Article II Contingent Value Rights 2.1 CVRs 5 2.2 Nontransferable 5 2.3 No Certificate; Registration |
|
| November 2, 2015 |
EX-99.1 5 d74734dex991.htm EXHIBIT 99.1 Exhibit 99.1 Press Release www.shire.com SHIRE TO ACQUIRE DYAX CORP, EXPANDING AND EXTENDING INDUSTRY-LEADING HEREDITARY ANGIODEMA (HAE) PORTFOLIO Lead pipeline product, DX-2930, is a Phase 3-ready asset, offering potentially transformative prophylactic therapy for HAE • DX-2930 has potential to expand HAE-treated patients and achieve annual worldwide sales |
|
| November 2, 2015 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 2, 2015 Dyax Corp. |
|
| November 2, 2015 |
AMENDED AND RESTATED DYAX CORP. ARTICLE I Exhibit 3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF DYAX CORP. ARTICLE I STOCKHOLDERS SECTION 1. Place of Meetings. All meetings of stockholders shall be held at the principal office of the corporation or at such other place as may be named in the notice. SECTION 2. Annual Meeting. The annual meeting of stockholders for the election of directors and the transaction of such other business as may |
|
| November 2, 2015 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Pro |
|
| November 2, 2015 |
Exhibit 99.1 Exhibit 99.1 Press Release www.shire.com SHIRE TO ACQUIRE DYAX CORP, EXPANDING AND EXTENDING INDUSTRY-LEADING HEREDITARY ANGIODEMA (HAE) PORTFOLIO Lead pipeline product, DX-2930, is a Phase 3-ready asset, offering potentially transformative prophylactic therapy for HAE ? DX-2930 has potential to expand HAE-treated patients and achieve annual worldwide sales of up to $2 billion with ex |
|
| November 2, 2015 |
EX-2.1 2 d74734dex21.htm EXHIBIT 2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER Among DYAX CORP., SHIRE PHARMACEUTICALS INTERNATIONAL, PARQUET COURTS, INC. and SHIRE PLC Dated as of November 2, 2015 TABLE OF CONTENTS Page ARTICLE I The Merger; Closing; Effective Time 1.1 The Merger 2 1.2 Closing 2 1.3 Effective Time 2 ARTICLE II Certificate of Incorporation and Bylaws of the Surviv |
|
| November 2, 2015 |
AMENDED AND RESTATED DYAX CORP. ARTICLE I Exhibit 3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF DYAX CORP. ARTICLE I STOCKHOLDERS SECTION 1. Place of Meetings. All meetings of stockholders shall be held at the principal office of the corporation or at such other place as may be named in the notice. SECTION 2. Annual Meeting. The annual meeting of stockholders for the election of directors and the transaction of such other business as may |
|
| November 2, 2015 |
Exhibit 2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER Among DYAX CORP., SHIRE PHARMACEUTICALS INTERNATIONAL, PARQUET COURTS, INC. and SHIRE PLC Dated as of November 2, 2015 TABLE OF CONTENTS Page ARTICLE I The Merger; Closing; Effective Time 1.1 The Merger 2 1.2 Closing 2 1.3 Effective Time 2 ARTICLE II Certificate of Incorporation and Bylaws of the Surviving Corporation 2.1 The C |
|
| October 28, 2015 |
Dyax Corp. Announces Third Quarter 2015 Financial Results Exhibit 99.1 Dyax Corp. Announces Third Quarter 2015 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-October 28, 2015-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2015. Dyax will host a webcast to review these results in conjunction with the Company?s Research and Development Day on Monday, November 2, 2015 at 8:00 a.m. (ET). Recent high |
|
| October 28, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 28, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| July 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 dyax10q6302015.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2015 Or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File N |
|
| July 29, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51152226.htm DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporat |
|
| July 29, 2015 |
Dyax Corp. Announces Second Quarter 2015 Financial Results EX-99.1 2 a51152226ex991.htm EXHIBIT 99.1 Exhibit 99.1 Dyax Corp. Announces Second Quarter 2015 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-July 29, 2015-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2015. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates on DX-2930, KALBI |
|
| May 14, 2015 |
8-K 1 a51102671.htm DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 12, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporati |
|
| May 14, 2015 |
Dyax Corp. Appoints Dr. Abbie Celniker to Board of Directors EX-99.1 2 a51102671ex991.htm EXHIBIT 99.1 Exhibit 99.1 Dyax Corp. Appoints Dr. Abbie Celniker to Board of Directors BURLINGTON, Mass.-(BUSINESS WIRE)-May 12, 2015-Dyax Corp. (NASDAQ: DYAX), a biopharmaceutical company focused on the development and commercialization of novel biotherapeutics for unmet medical needs, today announced the appointment of Abbie Celniker, Ph.D., to its Board of Directors |
|
| May 14, 2015 |
POWER OF ATTORNEY Know all by these presents,that the undersigned hereby constitutes and appoints each of Andrew D. |
|
| April 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 v40781110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2015 Or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. |
|
| April 29, 2015 |
Dyax Corp. Announces First Quarter 2015 Financial Results Exhibit 99.1 Dyax Corp. Announces First Quarter 2015 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-April 29, 2015-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the first quarter ended March 31, 2015. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers ? including DX-2930, KALBIT |
|
| April 29, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51091533.htm DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorpora |
|
| April 14, 2015 |
DEF 14A 1 v400245def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as pe |
|
| April 9, 2015 |
DYAX CORP. (a Delaware corporation) 7,400,000 Shares of Common Stock UNDERWRITING AGREEMENT Exhibit 1.1 DYAX CORP. (a Delaware corporation) 7,400,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: April 7, 2015 Execution Version DYAX CORP. (a Delaware corporation) 7,400,000 Shares of Common Stock UNDERWRITING AGREEMENT April 7, 2015 Merrill Lynch, Pierce, Fenner & Smith Incorporated Cowen and Company, LLC as Representatives of the several Underwriters c/o Merrill Lynch, Pierce, Fen |
|
| April 9, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 7, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| April 8, 2015 |
CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be Registered(1) Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Offering Price Amount of Registration Fee(2) Common Stock, $0. |
|
| April 6, 2015 |
424B5 1 v406325424b5.htm PROSPECTUS SUPPLEMENT The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has become effective immediately upon filing by rule of the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securit |
|
| April 6, 2015 |
Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 31, 2015 |
Dyax FORM 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 31, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 31, 2015 |
DX - 2930 Phase 1b Data Review MARCH 31, 2015 EX-99.1 2 v406167ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 DX - 2930 Phase 1b Data Review MARCH 31, 2015 This presentation contains forward - looking statements, including statements regarding the prospects for therapeutic benefits and treatment advantages of an investigational product, DX - 2930, being developed by Dyax for hereditary angioedema (HAE). Statements that are not historical facts are base |
|
| March 31, 2015 |
EX-99.2 3 v406167ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Contact: Jennifer Robinson Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Announces Positive Results from Phase 1b Clinical Trial of DX-2930 Management to Host Conference Call with Detailed Data Presentation Today at 5:00 p.m. ET BURLINGTON, MA, March 31, 2015 – Dyax Corp. (NASDAQ:DYAX) today an |
|
| February 27, 2015 |
SIXTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) EX-10.7(G) 3 v401127ex10-7g.htm EXHIBIT 10.7(G) Exhibit 10.7(g) SIXTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) This Sixth Amendment to the Distribution Services Agreement (this “Amendment”) is made and entered into as of October 21, 2014 (the “Amendment Effective Date”), by and between DYAX CORP. (“Dyax”) and ASD Specialty Healthcare, Inc. (“ASD”). WHEREAS, Dyax and AS |
|
| February 27, 2015 |
SEVENTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) Exhibit 10.7(h) SEVENTH AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) This Seventh Amendment to the Distribution Services Agreement (this ?Amendment?) is made and entered into as of December 3, 2014 (the ?Amendment Effective Date?), by and between DYAX CORP. (?Dyax?) and ASD Specialty Healthcare, Inc. (?ASD?). WHEREAS, Dyax and ASD entered into that certain Distribution Ser |
|
| February 27, 2015 |
Fifth AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) Exhibit 10.7(f) Fifth AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) This Fifth Amendment to the Distribution Services Agreement (this ?Amendment?) is made and entered into as of June 3, 2013 (the ?Amendment Effective Date?), by and between DYAX CORP. (?Dyax?) and ASD Specialty Healthcare, Inc. (?ASD?). WHEREAS, Dyax and ASD entered into that certain Distribution Services Ag |
|
| February 27, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 v40112710k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2014 OR o Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 000-24537 |
|
| February 27, 2015 |
Dyax Corp. Subsidiaries of the Company Exhibit 21.1 Dyax Corp. Subsidiaries of the Company NAME PARENT STATE OR COUNTRY OF INCORPORATION Dyax Holdings B.V. Dyax Corp. Netherlands |
|
| February 27, 2015 |
EX-10.8(C) 5 v401127ex10-8c.htm EXHIBIT 10.8(C) Exhibit 10.8(c) SECOND AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR® BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC. THIS SECOND AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR® (the “Amendment”) is made and entered into as of the 30th day of September 2013 (the “Second Amendment Effective Date”), by and bet |
|
| February 27, 2015 |
AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT Exhibit 10.13 Execution Version AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT This AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT ("Agreement"), dated effective as of , 20 (the "Effective Date"), is entered into between Dyax Corp., a Delaware corporation with offices at 55 Network Drive, Burlington, Massachusetts 01803 ("Dyax" or the "Company") and (the "Executive") amends and restates th |
|
| February 27, 2015 |
EX-10.8(D) 6 v401127ex10-8d.htm EXHIBIT 10.8(D) Exhibit 10.8(d) THIRD AMENDMENT TO THE DISTRIBUTION AGREEMENT BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC. THIS THIRD AMENDMENT TO THE DISTRIBUTION AGREEMENT (the “Amendment”) is made and entered into as of this 30th day of December, 2014, by and between DYAX CORP., a Delaware corporation (“Dyax”), and WALGREENS INFUSION SERVICES, |
|
| February 27, 2015 |
Exhibit 10.21 MASTER SERVICES AGREEMENT This Master Services Agreement (this "Agreement") is entered into this September 12, 2013, (the "Effective Date") by and between Sonexus Health, LLC and its affiliates, a Texas Limited Partnership having its principal place of business at 2730 S. Edmonds Lane, Ste. 300, Lewisville, TX 75067 ("Vendor"), and Dyax Corp., 55 Network Drive, Burlington, MA 01803, |
|
| February 27, 2015 |
Exhibit 10.8(e) FOURTH AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR? BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC. THIS FOURTH AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR? (the ?Fourth Amendment?) is made and entered into as of the 30th day of December 2014 (the ?Fourth Amendment Effective Date?), by and between DYAX CORP., a Delaware corporation (? |
|
| February 27, 2015 |
AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT Exhibit 10.12 Execution Version AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT This AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENT ("Agreement"), dated effective as of December 23, 2014 (the "Effective Date"), is entered into between Dyax Corp., a Delaware corporation with offices at 55 Network Drive, Burlington, Massachusetts 01803 ("Dyax" or the "Company") and Gustav Christensen (the "Ex |
|
| February 24, 2015 |
Dyax Corp. Announces Fourth Quarter and Full Year 2014 Financial Results EX-99.1 2 a51045602ex991.htm EXHIBIT 99.1 Exhibit 99.1 Dyax Corp. Announces Fourth Quarter and Full Year 2014 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-February 24, 2015-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2014. Dyax will host a webcast and conference call at 8:30 a.m. (ET) today to review financial results and pr |
|
| February 24, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 24, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 17, 2015 |
DYAX / Dyax Corp. / RA Capital Management, LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* DYAX CORP. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 13, 2015 |
DYAX / Dyax Corp. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0145 Washington, D. |
|
| February 11, 2015 |
DYAX / Dyax Corp. / FEDERATED INVESTORS INC /PA/ Passive Investment SC 13G/A 1 form.htm OMB APPROVAL OMB Number: 3235-0145 Estimated average burden hours per response ….11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 15)* DYAX CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2014 (Date of Event Which Require |
|
| January 12, 2015 |
1: January 2015 Corporate Presentation SubTitle: January 12, 2015 Exhibit 99.1 1: January 2015 Corporate Presentation SubTitle: January 12, 2015 2: Forward Looking Statements Other Placeholder: 2 This presentation contains forward-looking statements regarding Dyax’s business plans, strategies and outlook. These statements may include, without limitation: statements regarding the potential benefits and usage of KALBITOR® (ecallantide) for treating HAE; the commer |
|
| January 12, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 12, 2015 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| November 14, 2014 |
Exhibit 12.1 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES and RATIO of EARNINGS TO combined fixed charges and preferred stock dividends(1) The following table sets forth Dyax Corp.’s ratio of earnings to fixed charges for the periods indicated. YEARS ENDED DECEMBER 31, NINE MONTHS ENDED SEPTEMBER 30, (dollars in thousands) 2009 2010 2011 2012 2013 2014 Net (loss) from continuing operations $ |
|
| November 14, 2014 |
DYAX / Dyax Corp. S-3ASR - - S-3ASR As filed with the Securities and Exchange Commission on November 14, 2014. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DYAX CORP. (Exact name of registrant as specified in its charter) Delaware 04-3053198 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification |
|
| November 14, 2014 |
Dyax Corp. __________________________, as Trustee Dated as of ______________, _____ Exhibit 4.1 Dyax Corp. and , as Trustee INDENTURE Dated as of , INDENTURE, dated as of , , by and between Dyax Corp., a Delaware corporation, as Issuer (the “Company”), and , a organized under the laws of , as Trustee (the “Trustee”). RECITALS OF THE COMPANY The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debentures, |
|
| November 3, 2014 |
10-Q 1 v39171310q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2014 Or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File |
|
| October 28, 2014 |
Dyax Corp. Announces Third Quarter 2014 Financial Results EX-99.1 2 a50971319ex991.htm EXHIBIT 99.1 Exhibit 99.1 Dyax Corp. Announces Third Quarter 2014 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-October 28, 2014-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding i |
|
| October 28, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 28, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| September 23, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 23, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| August 19, 2014 |
DYAX / Dyax Corp. S-8 - - FORM S-8 S-8 1 v386978s8.htm FORM S-8 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 18, 2014 REGISTRATION NO. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DYAX CORP. (Exact name of registrant as specified in its charter) Delaware 04-3053198 (State or other jurisdiction of incorporation or organ |
|
| August 19, 2014 |
DYAX / Dyax Corp. S-8 - - FORM S-8 S-8 1 v386976s8.htm FORM S-8 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 18, 2014 REGISTRATION NO. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DYAX CORP. (Exact name of registrant as specified in its charter) Delaware 04-3053198 (State or other jurisdiction of incorporation or organ |
|
| August 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2014 Or ? Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to .. Commission File No. 000-24537 DYAX CORP. (Exact Name |
|
| July 29, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 29, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| July 29, 2014 |
Dyax Corp. Announces Second Quarter 2014 Financial Results Exhibit 99.1 Dyax Corp. Announces Second Quarter 2014 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-July 29, 2014-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the hereditary angioedema |
|
| May 13, 2014 |
DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN Exhibit 10.1 Approved by the Stockholders on May 8, 2014 DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN Section 1. Purpose The purpose of the Dyax Corp. 1995 Equity Incentive Plan (the “Plan”) is to attract and retain key employees and directors and consultants of the Company and its Affiliates, to provide an incentive for them to assist the Company to achieve long-range performance go |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 8, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| May 13, 2014 |
DYAX CORP. 1998 Employee Stock Purchase Plan Exhibit 10.2 Approved by the Stockholders on May 8, 2014 DYAX CORP. 1998 Employee Stock Purchase Plan 1. Purpose. The purpose of this 1998 Employee Stock Purchase Plan (the “Plan”) is to provide employees of Dyax Corp. (the “Company”), and its subsidiaries incorporated under the laws of a jurisdiction within the United States of America (“US Subsidiaries”), who wish to become shareholders of the C |
|
| May 2, 2014 |
AMENDED AND RESTATED SECOND TECHNOLOGY TRANSFER AND LICENSE AGREEMENT EX-10.2 3 a50852874ex102.htm EXHIBIT 10.2 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.2 AMEND |
|
| May 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 a50852874.htm DYAX CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2014 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File |
|
| May 2, 2014 |
DYAX / Dyax Corp. / RA Capital Management, LLC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* DYAX CORP. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 26746E103 (CUSIP Number) April 25, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| May 2, 2014 |
DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT CERTIFICATE EX-10.1 2 a50852874ex101.htm EXHIBIT 10.1 Exhibit 10.1 DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT CERTIFICATE (Employees) Certificate Number: RSU- Units This Restricted Stock Unit Certificate (this “Certificate”) confirms that Dyax Corp. (“Dyax” or the “Company”), a Delaware corporation, has on the date set forth below (the “Award Date”) granted to the person |
|
| April 30, 2014 |
Dyax Corp. Announces First Quarter 2014 Financial Results Exhibit 99.1 Dyax Corp. Announces First Quarter 2014 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-April 30, 2014-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the first quarter ended March 31, 2014. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the hereditary angioedema |
|
| April 30, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 30, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| April 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| April 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 3, 2014 |
Financial Statements and Exhibits, Other Events - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 3, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| April 3, 2014 |
Exhibit 99.1 Dyax Receives FDA Approval to Expand Use of KALBITOR® (ecallantide) for the Treatment of Acute Attacks of Hereditary Angioedema to Patients 12 Years of Age and Older BURLINGTON, Mass.-(BUSINESS WIRE)-April 3, 2014-Dyax Corp. (NASDAQ:DYAX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide i |
|
| March 18, 2014 |
Dyax Corp. 8,000,000 Shares Common Stock ($0.01 par value per Share) Underwriting Agreement EX-1.1 2 v371969ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 Dyax Corp. 8,000,000 Shares Common Stock ($0.01 par value per Share) Underwriting Agreement March 14, 2014 Underwriting Agreement March 14, 2014 Jefferies LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: Dyax Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule A annexe |
|
| March 18, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 v3719698k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 14, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) |
|
| March 17, 2014 |
424B5 1 v371742424b5.htm 424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-192065 Prospectus Supplement (To Prospectus Dated November 15, 2013) 8,000,000 Shares Dyax Corp. Common Stock We are offering 8,000,000 shares of our common stock. Our common stock is traded on The Nasdaq Global Market under the symbol “DYAX.” On March 13, 2014, the last reported sale price of our common stock was |
|
| March 13, 2014 |
424B5 1 v370908424b5.htm 424B5 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, and we are not soliciting offers to |
|
| March 3, 2014 |
Dyax Corp. Subsidiaries of the Company Exhibit 21.1 Dyax Corp. Subsidiaries of the Company NAME PARENT STATE OR COUNTRY OF INCORPORATION Dyax Holdings B.V. Dyax Corp. Netherlands Dyax B.V. Dyax Holdings B.V. Netherlands Dyax S.A. Dyax Corp. Belgium |
|
| March 3, 2014 |
10-K 1 a50812102.htm DYAX CORP. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2013 OR o Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number |
|
| February 28, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 28, 2014 |
Dyax Corp. Announces Fourth Quarter and Full Year 2013 Financial Results Exhibit 99 Dyax Corp. Announces Fourth Quarter and Full Year 2013 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-February 28, 2014-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2013. Dyax will host a webcast and conference call at 8:30 a.m. (ET) today to review financial results and provide updates regarding its key value driver |
|
| February 26, 2014 |
Exhibit 99.1 Dyax Announces Positive Results from Phase 1a Clinical Trial of DX-2930 Data Advances Development of a Prophylactic Treatment for Hereditary Angioedema; Phase 1b Clinical Trial Planned for Mid-2014 Management to Host Conference Call with Detailed Data Presentation Today at 5:00 p.m. ET BURLINGTON, Mass.-(BUSINESS WIRE)-February 25, 2014-Dyax Corp. (NASDAQ:DYAX) today announced positiv |
|
| February 26, 2014 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 25, 2014 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 14, 2014 |
DYAX / Dyax Corp. / RA Capital Management, LLC - SC 13G/A Passive Investment SC 13G/A 1 v368718sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* DYAX CORP. (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 14, 2014 |
DYAX / Dyax Corp. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . . 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Dyax Corp. (Name of Issuer) Common (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2013 (Date of Event Whic |
|
| February 12, 2014 |
DYAX / Dyax Corp. / VANGUARD GROUP INC Passive Investment dyaxcorp.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Dyax Corp Title of Class of Securities: Common Stock CUSIP Number: 26746E103 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate the |
|
| January 10, 2014 |
DYAX / Dyax Corp. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response . |
|
| December 10, 2013 |
Termination of a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 4, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| November 1, 2013 |
Exhibit 12.1 COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES and RATIO of EARNINGS TO combined fixed charges and preferred stock dividends(1) The following table sets forth Dyax Corp.’s ratio of earnings to fixed charges for the periods indicated. YEARS ENDED DECEMBER 31, NINE MONTHS ENDED SEPTEMBER 30, (dollars in thousands) 2008 2009 2010 2011 2012 2013 Net (loss) from continuing operations $ |
|
| November 1, 2013 |
S-3 1 v358393s3.htm FORM S-3 As filed with the Securities and Exchange Commission on November 1, 2013. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DYAX CORP. (Exact name of registrant as specified in its charter) Delaware 04-3053198 (State or other jurisdiction of incorporation or organization) (I. |
|
| November 1, 2013 |
Dyax Corp. __________________________, as Trustee Dated as of ______________, _____ Exhibit 4.1 Dyax Corp. and , as Trustee INDENTURE Dated as of , INDENTURE, dated as of , , by and between Dyax Corp., a Massachusetts corporation, as Issuer (the “Company”), and , a organized under the laws of , as Trustee (the “Trustee”). RECITALS OF THE COMPANY The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debent |
|
| November 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2013 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-24537 DYAX CORP. (Exact |
|
| October 22, 2013 |
Dyax Corp. Announces Third Quarter 2013 Financial Results Exhibit 99.1 Dyax Corp. Announces Third Quarter 2013 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-October 22, 2013-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2013. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the Hereditary Angi |
|
| October 22, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| October 11, 2013 |
Exhibit 1.1 Dyax Corp. 9,230,770 Shares Common Stock ($0.01 par value per Share) Underwriting Agreement October 9, 2013 Underwriting Agreement October 9, 2013 Jefferies LLC 520 Madison Avenue New York, New York 10022 Ladies and Gentlemen: Dyax Corp., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule A annexed hereto (the “Underwriters”), for w |
|
| October 11, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 9, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| October 10, 2013 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-171405 Prospectus Supplement (To Prospectus Dated January 6, 2011) 9,230,770 Shares Dyax Corp. Common Stock We are offering 9,230,770 shares of our common stock. Our common stock is traded on The Nasdaq Global Market under the symbol “DYAX.” On October 8, 2013, the last reported sale price of our common stock was $6.65 per share. Investing in o |
|
| October 8, 2013 |
424B5 1 v356832424b5.htm 424B5 The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, and we are not soliciting offers to |
|
| October 8, 2013 |
Regulation FD Disclosure, Results of Operations and Financial Condition - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 2, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| August 29, 2013 |
Termination of a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 23, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| August 2, 2013 |
EX-10.1 2 a50681369ex101.htm EXHIBIT 10.1 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.1 SUPPL |
|
| August 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 a50681369.htm DYAX CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2013 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File |
|
| July 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 25, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| July 29, 2013 |
DYAX CORP. 55 Network Drive Burlington, MA 01803 July 29, 2013 VIA EDGAR SUBMISSION Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4720 Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: Dyax Corp. Form 10-K for the Fiscal Year Ended December 31, 2012 Filed March 4, 2013 File No. 000-24537 Dear Mr. Rosenberg: On behalf of Dyax Corp. (“Dyax” o |
|
| July 24, 2013 |
Dyax Corp. Announces Second Quarter 2013 Financial Results Exhibit 99.1 Dyax Corp. Announces Second Quarter 2013 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-July 24, 2013-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2013. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the KALBITOR® (ecallantid |
|
| July 24, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 24, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| July 17, 2013 |
EX-10.3 3 a50671339ex103.htm EXHIBIT 10.3 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.3 COMME |
|
| July 17, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.2 HUB SERVICES AGREEMENT This HUB SERVICES AGREEM |
|
| July 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 10-Q/A 1 a50671339.htm DYAX CORP. 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period fro |
|
| July 2, 2013 |
DYAX CORP. 55 Network Drive Burlington, MA 01803 July 2, 2013 VIA EDGAR SUBMISSION Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4720 Washington, D.C. 20549 Attention: Jim B. Rosenberg, Senior Assistant Chief Accountant Re: Dyax Corp. Form 10-K for the fiscal year ended December 31, 2012 Filed March 4, 2013 File No. 000-24537 Dear Mr. Rosenberg: On behalf of Dyax Corp., we acknow |
|
| June 27, 2013 |
Regulation FD Disclosure - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 25, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| June 25, 2013 |
Entry into a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| May 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 10, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| May 16, 2013 |
FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.1 FORM OF SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of May 10, 2013, between Dyax Corp., a Delaware Corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to a |
|
| May 16, 2013 |
Exhibit 3.1 DYAX CORP. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES 1 CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Gustav A. Christensen and Andrew D. Ashe, do hereby certify that: 1. They are the President and Assistant Secretary, respectively, of Dyax Corp., a Delaware corporation (the “Corporation”). |
|
| May 16, 2013 |
THIS CERTIFICATE AND THE SHARES REPRESENTED HEREBY ARE ISSUED AND SHALL BE HELD SUBJECT TO ALL THE PROVISIONS OF THE CERTIFICATE OF INCORPORATION AND THE BYLAWS OF THE CORPORATION AND ANY AMENDMENTS THERETO, AND TO THE RIGHTS, PREFERENCES AND VOTING POWERS OF THE PREFERRED STOCK OF THE CORPORATION NOW OR HEREAFTER OUTSTANDING. |
|
| May 16, 2013 |
Dyax Announces $30 Million Offering Exhibit 99.1 Contact: Jennifer Robinson Associate Director, Investor Relations and Corporate Communications (617) 250-5741 [email protected] Dyax Announces $30 Million Offering Burlington, MA, May 13, 2013 – Dyax Corp. (NASDAQ: DYAX) announced today that it has priced a registered direct offering with RA Capital Management, Venrock, Federated Investors, Inc. and one other institutional investor f |
|
| May 15, 2013 |
Submission of Matters to a Vote of Security Holders - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| May 15, 2013 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-171405 Prospectus Supplement (To Prospectus Dated January 6, 2011) Dyax Corp. 8,901,675 Shares of Common Stock 41,418 Shares of Series 1 Convertible Preferred Stock 4,141,800 Shares of Common Stock Issuable Upon Conversion of the Series 1 Convertible Preferred Stock We are offering directly to investors up to 8,901,675 shares of our common stoc |
|
| May 13, 2013 |
SUBJECT TO COMPLETION, DATED MAY 10, 2013 SUBJECT TO COMPLETION, DATED MAY 10, 2013 Filed Pursuant to Rule 424(b)(5) Registration No. |
|
| May 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 a50618956.htm DYAX CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2013 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File |
|
| May 2, 2013 |
EX-10.3 3 a50618956ex103.htm EXHIBIT 10.3 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.3 COMME |
|
| May 2, 2013 |
EX-10.2 2 a50618956ex102.htm EXHIBIT 10.2 Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.2 HUB S |
|
| April 25, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 25, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| April 25, 2013 |
Dyax Corp. Announces First Quarter 2013 Financial Results Exhibit 99.1 Dyax Corp. Announces First Quarter 2013 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-April 25, 2013-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the first quarter ended March 31, 2013. The Company will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR® (ecallantide |
|
| April 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 2, 2013 |
Termination of a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 27, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 29, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.3 DISTRIBUTION SERVICES AGREEMENT (Wholesale Dist |
|
| March 29, 2013 |
CONFIDENTIAL Exhibit 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT ("Agreement"), dated effective as of March 29, 2013 (the "Effective Date"), is entered into by and between Dyax Corp., a Delaware corporation with a principal place of business at 55 Network Drive, Burlington, MA 01803 ("Dyax" or “the Company”) and Ivana Magovcevic-Liebisch of 208 Collins Road, Waban Massachusetts 02468 ("Con |
|
| March 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 29, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 29, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.2 SERVICES AGREEMENT (Specialty Pharmacy and Hub |
|
| March 29, 2013 |
DISTRIBUTION SERVICES AGREEMENT (3PL Services) Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.4 DISTRIBUTION SERVICES AGREEMENT (3PL Services) |
|
| March 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 4, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 8, 2013 |
Exhibit 99.1 Dyax Announces Management Change Ivana Magovcevic-Liebisch, Ph.D., J.D., Executive Vice President, Chief Operating Officer, to Leave the Company BURLINGTON, Mass.-(BUSINESS WIRE)-March 8, 2013-Dyax Corp. (NASDAQ: DYAX) today announced that Ivana Magovcevic-Liebisch, Ph.D., J.D., Executive Vice President, Chief Operating Officer, will leave the Company to pursue a senior management opp |
|
| March 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 a50574444.htm DYAX CORP. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2012 OR o Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number |
|
| March 4, 2013 |
Exhibit 10.7(d) THIRD AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) This Third Amendment to the Distribution Services Agreement (this ?Amendment?) is made and entered into as of December 3, 2012 (the ?Amendment Effective Date?), by and between DYAX CORP. (?Dyax?) and ASD Specialty Healthcare, Inc. (?ASD?). WHEREAS, Dyax and ASD entered into that certain Distribution Service |
|
| March 4, 2013 |
Dyax Corp. Subsidiaries of the Company EX-21.1 7 a50574444ex211.htm EXHIBIT 21.1 Exhibit 21.1 Dyax Corp. Subsidiaries of the Company NAME PARENT STATE OR COUNTRY OF INCORPORATION Dyax Holdings B.V. Dyax Corp. Netherlands Dyax B.V. Dyax Holdings B.V. Netherlands Dyax S.A. Dyax Corp. Belgium |
|
| March 4, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.8(b) August 30, 2011 AGREEMENT FOR SERVICES RELAT |
|
| March 4, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.8(a) DISTRIBUTION AGREEMENT This Distribution Agr |
|
| March 4, 2013 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks [*****] denote such omission. CONFIDENTIAL DOCUMENT Exhibit 10.7(e) FOURTH AMENDMENT TO DISTRIBUTION SERVICES AG |
|
| March 4, 2013 |
SECOND AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) Exhibit 10.7(C) SECOND AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT (Wholesale Distribution) This Second Amendment to the Distribution Services Agreement (this ?Amendment?) is made and entered into as of July 31, 2012 (the ?Amendment Effective Date?), by and between DYAX CORP. (?Dyax?) and ASD Specialty Healthcare, Inc. (?ASD?). WHEREAS, Dyax and ASD entered into that certain Distribution Services |
|
| February 19, 2013 |
Entry into a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 12, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 14, 2013 |
DYAX / Dyax Corp. / RA CAPITAL MANAGEMENT, L.P. - SC 13G/A Passive Investment SC 13G/A 1 v335087sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* DYAX CORP. (Name of Issuer) Common Stock, par value $0.01 (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 14, 2013 |
DYAX / Dyax Corp. / PRIMECAP MANAGEMENT CO/CA/ - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response. . . . . . . . 10.4 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Dyax Corp. (Name of Issuer) Common (Title of Class of Securities) 26746E103 (CUSIP Number) December 31, 2012 (Date of Event Whic |
|
| February 13, 2013 |
Dyax Corp. Announces Fourth Quarter and Full Year 2012 Financial Results Exhibit 99.1 Dyax Corp. Announces Fourth Quarter and Full Year 2012 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-February 13, 2013-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - th |
|
| February 13, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 13, 2013 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 12, 2013 |
DYAX / Dyax Corp. / FEDERATED HERMES, INC. Passive Investment OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response . |
|
| February 11, 2013 |
DYAX / Dyax Corp. / VANGUARD GROUP INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Dyax Corp Title of Class of Securities: Common Stock CUSIP Number: 26746E103 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: (X) Rule 1 |
|
| October 29, 2012 |
EX-10.1 2 a50455617ex101.htm EXHIBIT 10.1 Exhibit 10.1 Private & Confidential CONFIDENTIAL TREATMENT Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. DATED JULY 26, 2012 MEDIMMUNE LIMITED (1) and DYAX CORP. (2) 2012 AMENDED AND RESTATED LICENSE AGREEMENT Confidential |
|
| October 29, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2012 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-24537 DYAX CORP. (Exact |
|
| October 24, 2012 |
Dyax Corp. Announces Third Quarter 2012 Financial Results Exhibit 99.1 Dyax Corp. Announces Third Quarter 2012 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-October 24, 2012-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the third quarter ended September 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the KALBITOR® (ecal |
|
| October 24, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| October 17, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 16, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| October 17, 2012 |
Dyax Corp. Appoints Marc Kozin to Board of Directors Exhibit 99.1 Dyax Corp. Appoints Marc Kozin to Board of Directors BURLINGTON, Mass.-(BUSINESS WIRE)-October 16, 2012-Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, announced today the appointment of Marc Kozin to its Board of Directors. “Marc brings to our Board nearly 30 years of domestic and international experience in strategy consulting and a deep unde |
|
| August 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 22, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IR |
|
| August 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| August 20, 2012 |
Exhibit 99.1 Dyax Corp. Creates COO Position and Expands Executive Roles Ivana Magovcevic-Liebisch, Ph.D., J.D., Named Chief Operating Officer, Burt Adelman, M.D., Named Executive Vice President BURLINGTON, Mass.-(BUSINESS WIRE)-August 20, 2012-Dyax Corp. (NASDAQ: DYAX) today announced the appointment of Ivana Magovcevic-Liebisch, Ph.D., J.D., to the new position of Executive Vice President, Chief |
|
| August 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2012 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File No. 000-24537 DYAX CORP. (Exact Name |
|
| August 2, 2012 |
EX-10.1 2 a50358486ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 CONFIDENTIAL TREATMENT Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. CONFIDENTIAL DOCUMENT FINAL MAY 29, 2012 FOURTH AMENDMENT TO JOINT DEVELOPMENT AND LICENSE AGREEMENT This FOURTH AMENDMENT (the "Fourth Amen |
|
| August 2, 2012 |
EX-10.2 3 a50358486ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 CONFIDENTIAL TREATMENT Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. FIFTH AMENDMENT TO JOINT DEVELOPMENT AND LICENSE AGREEMENT This FIFTH AMENDMENT (the "Fifth Amendment"), dated as of June 21, 2012 (the "Fif |
|
| August 2, 2012 |
Exhibit 10.3 CONFIDENTIAL TREATMENT Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. THIS AGREEMENT is made this 29th day of June 2012 between: (1) FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED of Belasis Avenue, Billingham, TS23 1LH, England ("Fujifilm"); and (2) DYAX |
|
| August 1, 2012 |
Entry into a Material Definitive Agreement - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 26, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| July 19, 2012 |
Dyax Corp. Announces Second Quarter 2012 Financial Results Exhibit 99.1 Dyax Corp. Announces Second Quarter 2012 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-July 19, 2012-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the second quarter ended June 30, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the KALBITOR® (ecallantid |
|
| July 19, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 19, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| July 11, 2012 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 2, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| June 28, 2012 |
S-8 1 v317158s-8.htm FORM S-8 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JUNE 28, 2012 REGISTRATION NO. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 DYAX CORP. (Exact name of registrant as specified in its charter) Delaware 04-3053198 (State or other jurisdiction of incorporation or organi |
|
| June 28, 2012 |
DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN EX-99.1 4 v317158ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 As amended through February 9, 2012 DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN Section 1. Purpose The purpose of the Dyax Corp. 1995 Equity Incentive Plan (the “Plan”) is to attract and retain key employees and directors and consultants of the Company and its Affiliates, to provide an incentive for them to assist the Company to |
|
| June 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 21, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| June 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 20, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| June 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 1) DYAX CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Options to Purchase Common Stock, $0.01 par value (Title of Class of Securities) 26746E103 (CUSIP Number of Class |
|
| June 21, 2012 |
NOTICE OF EXPIRATION OF OFFER AND ACCEPTANCE OF OPTIONS TENDERED FOR EXCHANGE Exhibit (a)(1)(J) NOTICE OF EXPIRATION OF OFFER AND ACCEPTANCE OF OPTIONS TENDERED FOR EXCHANGE We are pleased to announce that we have completed the Company’s stock option exchange program. |
|
| June 14, 2012 |
Financial Statements and Exhibits, Other Events - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 14, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| June 14, 2012 |
Exhibit 99.1 Dyax Reports Results of Interim Analysis of Phase 2 Trial of Ecallantide for Acute Treatment of ACE Inhibitor-Induced Angioedema BURLINGTON, Mass.-(BUSINESS WIRE)-June 14, 2012-Dyax Corp. (NASDAQ: DYAX) announced today the decision to discontinue the Company’s Phase 2 trial investigating ecallantide in the acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioe |
|
| June 5, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 5, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| June 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 29, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS E |
|
| May 21, 2012 |
Exhibit (a)(1)(G) Sent: , 2012 From: Option Exchange To: Subject: Reminder: Option Exchange Program Expires at 1:00 PM on June 19, 2012 As of today, our records show you have not made an election to participate in the company's option exchange program. |
|
| May 21, 2012 |
Employee Presentation Stock Option Exchange Program May 2012 discover develop commercialize Exhibit (a)(1)(H) Disclaimer: » The following presentation is being presented for the benefit of the Company’s non - executive employees . |
|
| May 21, 2012 |
EX-99.A.1.B 3 v314057ex-a1b.htm EXHIBIT (A)(1)(B) Exhibit (a)(1)(B) Dyax Corp. 55 Network Drive Burlington, MA 01803 May 21, 2012 To: [Name] From: Gustav Christensen, President and Chief Executive Officer RE: Launch of Option Exchange Program Dear [Name]: It gives me great pleasure to announce that Dyax is today launching a stock option exchange program, whereby we are offering to exchange certain |
|
| May 21, 2012 |
DYAX CORP. OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW OPTIONS WITHDRAWAL FORM Exhibit (a)(1)(E) DYAX CORP. OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW OPTIONS WITHDRAWAL FORM Before submitting this Withdrawal Form, please make sure you have received, read and understand the documents that make up this offer (the "Offering Documents"), including: (1) the Offer to Exchange Certain Outstanding Options for new options (the “Offer to Exchange”); (2) the related Cover L |
|
| May 21, 2012 |
DYAX CORP. OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW OPTIONS ELECTION FORM Exhibit (a)(1)(D) DYAX CORP. OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW OPTIONS ELECTION FORM Before submitting this Election Form, please make sure you have received, read and understand the documents that make up this offer (the "Offering Documents"), including: (1) the Offer to Exchange Certain Outstanding Options for new options (the “Offer to Exchange”); (2) the related Cover Lette |
|
| May 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYAX CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Options to Purchase Common Stock, $0.01 par value (Title of Class of Securities) 26746E103 (CUSIP Number of Class of Securities (Com |
|
| May 21, 2012 |
Exhibit (a)(1)(F) Sent: , 2012 From: Option Exchange To: Subject: Rejection of Election Form In connection with the option exchange program described in that certain Offer to Exchange Certain Outstanding Stock Options for New Stock Options, dated May 21, 2012 (the "Offer"), we received an Election Form from you dated , 2012. |
|
| May 21, 2012 |
It gives me great pleasure to announce that Dyax is today launching a Exhibit (a)(1)(C) Sent: May 21, 2012 From: Gustav Christensen To: All Dyax, Board of Directors Subject: Launch of Option Exchange Program It gives me great pleasure to announce that Dyax is today launching a stock option exchange program, whereby we are offering to exchange certain "underwater" options (meaning that the option exercise price is currently significantly higher than the trading price of our common stock) for a fewer number of new options at a lower exercise price. |
|
| May 21, 2012 |
Exhibit (a)(1)(I) Sent: A.M. / P.M., , 2012 From: To: Subject: Option Exchange Program – New Option Grant Confirmation Thank you for participating in Dyax's option exchange program. The eligible options that you elected to exchange have been accepted for exchange and cancelled, and your new options have been granted, as indicated in the table below. The number of common shares subject to each of y |
|
| May 21, 2012 |
Exhibit (a)(1)(A) DYAX CORP. OFFER TO EXCHANGE CERTAIN OUTSTANDING OPTIONS FOR NEW OPTIONS May 21, 2012 DYAX CORP. Offer to Exchange Certain Outstanding Options for New Options This offer and withdrawal rights will expire at 1:00 p.m., Eastern Time, on June 19, 2012 unless we extend them By this offer, Dyax Corp. ("Dyax," the "Company," "we," "our," or "us") is offering certain active employees, o |
|
| May 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(D) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Em |
|
| May 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q 10-Q 1 a50259061.htm DYAX CORP. 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended March 31, 2012 Or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to . Commission File |
|
| May 2, 2012 |
Exhibit 10.1 SECOND AMENDMENT TO LEASE This Second Amendment to Lease (?Amendment?) is made and entered into as of this 5th day of January, 2012 by and between NetView 5 and 6 LLC (?Landlord?) and Dyax Corp (?Tenant?). BACKGROUND A. Landlord and Tenant entered into an office lease dated July 14, 2011, as amended by a First Amendment to Lease dated as of November 4, 2011 (collectively the ?Lease?) |
|
| April 24, 2012 |
Dyax Corp. Announces First Quarter 2012 Financial Results Exhibit 99.1 Dyax Corp. Announces First Quarter 2012 Financial Results BURLINGTON, Mass.-(BUSINESS WIRE)-April 24, 2012-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the first quarter ended March 31, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and provide updates regarding its key value drivers – the KALBITOR® (ecallantid |
|
| April 24, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 24, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| April 11, 2012 |
SC TO-C 1 v308876sctoc.htm SCHEDULE TO-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 13e-4) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 DYAX CORP. (Name of Subject Company (Issuer) and Filing Person (Offeror)) Options to Purchase Common Stock, $0.01 par value (Title of Class of Securities) 26746E103 |
|
| April 11, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 30, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS |
|
| March 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| March 2, 2012 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Exhibit 10.8(b) CONFIDENTIAL DOCUMENT AMENDMENT TO SERVICES AGREEMENT (Specialty Pharmacy and Hub Services) This Amendment to the Services Agreement (this ?Amendment?) is made and entered into as of February 15, 2011 (t |
|
| March 2, 2012 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Exhibit 10.8(c) CONFIDENTIAL DOCUMENT AMENDMENT TO SERVICES AGREEMENT (Specialty Pharmacy and Hub Services) This Amendment to the Services Agreement (this ?Amendment?) is made and entered into as of May 31, 2011 (the ?A |
|
| March 2, 2012 |
Dyax Corp. Subsidiaries of the Company EX-21.1 8 a50184012ex21-1.htm EXHIBIT 21.1 Exhibit 21.1 Dyax Corp. Subsidiaries of the Company NAME PARENT STATE OR COUNTRY OF INCORPORATION Dyax Holdings B.V. Dyax Corp. Netherlands Dyax B.V. Dyax Holdings B.V. Netherlands Dyax S.A. Dyax Corp. Belgium |
|
| March 2, 2012 |
Exhibit 10.1(e) DYAX CORP. AMENDED AND RESTATED 1995 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT CERTIFICATE (Employees) RSU Number: Units This Restricted Stock Unit Certificate (this ?Certificate?) confirms that Dyax Corp. (the ?Company?), a Delaware corporation, has on the date set forth below (the ?Award Date?) granted to the person named below (?Participant?) an award (the ?Award?) of the numb |
|
| March 2, 2012 |
THIRD AMENDMENT JOINT DEVELOPMENT AND LICENSE AGREEMENT Exhibit 10.14(c) THIRD AMENDMENT TO JOINT DEVELOPMENT AND LICENSE AGREEMENT This THIRD AMENDMENT (the "Third Amendment"), dated as of December 26, 2011 (the "Third Amendment Date"), is entered into by and between Dyax Corp., with effective offices at 300 Technology Square, Cambridge, Massachusetts 02139, U.S.A. ("Dyax"), and DefianteFarmac?utica S.A., with registered offices at Rua da Alf?ndega, n |
|
| March 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K 10-K 1 a50184012.htm DYAX CORP. 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2011 OR o Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number |
|
| March 2, 2012 |
Exhibit 10.18(b) FIRST AMENDMENT TO LEASE This First Amendment to Lease (?Amendment?) is made and entered into as of this 4th day of November, 2011 (the ?Effective Date?) by and between NetView 5 and 6 LLC (?Landlord?) and Dyax Corp (?Tenant?). BACKGROUND A. Landlord and Tenant entered into an office lease dated July 14, 2011 (the ?Lease?) for premises (the ?Original Premises?) containing approxim |
|
| March 2, 2012 |
Dyax Corp. has requested that portions of this document be accorded confidential treatment pursuant to Rule 24b-2 promulgated under the Securities Exchange Act of 1934, as amended. Exhibit 10.19 CONFIDENTIAL DOCUMENT EXECUTION VERSION LOAN AGREEMENT Dated as of December 29, 2011 Between LFRP INVESTORS, L.P., as Lender, and DYAX CORP., as Borrower Confidential materials omitted and filed separately |
|
| February 22, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - DYAX CORP. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2012 DYAX CORP. (Exact Name of Registrant as Specified in Charter) Delaware 000-24537 04-3053198 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| February 22, 2012 |
Exhibit 99.1 Dyax Corp. Announces Fourth Quarter and Full Year 2011 Financial Results Company Announces Corporate Initiatives to Focus On and Grow the Angioedema Franchise and LFRP BURLINGTON, Mass.-(BUSINESS WIRE)-February 22, 2012-Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2011. Dyax will host a webcast and conference call at 5: |
